Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
New brain cancer study findings have been reported by P. Kremer and colleagues
April 7th, 2009
According to recent research published in the journal Neurosurgery, "The newly developed conjugate 5-aminofluorescein (AFL)-human serum albumin (HSA) was investigated in a clinical trial for fluorescence-guided surgery of malignant brain tumors to assess its efficacy and tolerability. AFL, covalently linked to human serum albumin at a molar ratio of 1:1, was administered intravenously 0.5 to 4 clays before surgery at 0.5 or 1.0 mg/kg of body weight to 13 patients aged 38 to 71 years Who Were Suspected of having malignant gliomas." "Fluorescence guidance using a 488-nm argon laser was performed during Surgery at will, The extent of tumor resection was verified by...
Source: Cancer Weekly (2009-04-07)
|
